title: Visual field testing in the management of cytomegalovirus retinitis.
abstract: BACKGROUND
  Sequential visual field testing is an extremely helpful adjunct to ophthalmoscopy and fundus photography in the management of cytomegalovirus (CMV) retinitis with the antiviral agents ganciclovir or foscarnet in patients with the acquired immune deficiency syndrome (AIDS). The authors studied the visual field defects found in a series of 110 patients with AIDS and CMV retinitis.
  
  
  METHODS
  Ophthalmoscopy and fundus photography were performed on all patients. Visual field analysis was performed with either tangent screen, Goldmann kinetic, or Humphrey automated static perimetry.
  
  
  RESULTS
  Of 166 eyes in 110 patients with CMV retinitis, visual field defects were present initially in 92 (55%) eyes of 78 (70%) patients, and ultimately in 97 (53%) eyes of 90 patients in whom follow-up was available. Stabilization of visual field defects was indicative of controlled retinitis.
  
  
  CONCLUSIONS
  Sequential visual field testing will confirm ophthalmoscopic evidence of successful antiviral treatment of CMV retinitis and will corroborate very early progression of previously controlled retinitis.
authors.affiliation: Department of Ophthalmology, Washington Hospital Center, Washington, DC.
authors.forename: D M
authors.initials: DM
authors.lastname: Bachman
authors.forename: L M
authors.initials: LM
authors.lastname: Bruni
authors.forename: R A
authors.initials: RA
authors.lastname: DiGioia
authors.forename: P J
authors.initials: PJ
authors.lastname: Harris
authors.forename: C M
authors.initials: CM
authors.lastname: McMackin
authors.forename: M C
authors.initials: MC
authors.lastname: Pistole
authors.forename: R M
authors.initials: RM
authors.lastname: Thomas
authors.forename: D J
authors.initials: DJ
authors.lastname: Ward
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy; D015828:Eye Infections, Viral / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D017245:Foscarnet / Q000627:therapeutic use; D005654:Fundus Oculi; D015774:Ganciclovir / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000175:diagnosis; D006801:Humans; D008297:Male; D009887:Ophthalmoscopy; D010781:Photography; D012173:Retinitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D014786:Vision Disorders / Q000175:diagnosis* / Q000188:drug therapy; D058609:Visual Field Tests; D014794:Visual Fields
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir